{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:47:59Z","timestamp":1787827679723,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.acra.2025.05.056","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T16:18:37Z","timestamp":1750868317000},"page":"6555-6569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic Performance of Radiomics for Differentiating Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"32","author":[{"given":"Dingbang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.acra.2025.05.056_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.acra.2025.05.056_bib2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.acra.2025.05.056_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.21037\/hbsn.2017.01.02","article-title":"Epidemiology and risk factors: intrahepatic cholangiocarcinoma","volume":"6","author":"Gupta","year":"2017","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"8","key":"10.1016\/j.acra.2025.05.056_bib4","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1007\/s13277-015-3261-1","article-title":"Differentially expressed gene profiles of intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and combined hepatocellular-cholangiocarcinoma by integrated microarray analysis","volume":"36","author":"Xue","year":"2015","journal-title":"Tumour Biol J Int Soc Oncodevelopmental Biol Med"},{"issue":"2","key":"10.1016\/j.acra.2025.05.056_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/hep.30319","article-title":"Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma, and primary sclerosing cholangitis","volume":"70","author":"Banales","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.acra.2025.05.056_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1073274817729245","article-title":"Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"24","author":"Massarweh","year":"2017","journal-title":"Cancer Control"},{"issue":"1","key":"10.1016\/j.acra.2025.05.056_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000508442","article-title":"Prognostic value of pretreatment serum CA199 in patients with locally advanced rectal cancer treated with CRT followed by TME with normal pretreatment carcinoembryonic antigen levels","volume":"38","author":"Huang","year":"2021","journal-title":"Dig Surg"},{"issue":"5","key":"10.1016\/j.acra.2025.05.056_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23158","article-title":"The diagnostic value of PIVKA-II, AFP, AFP-L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma","volume":"34","author":"Qi","year":"2020","journal-title":"J Clin Lab Anal"},{"issue":"24","key":"10.1016\/j.acra.2025.05.056_bib9","doi-asserted-by":"crossref","first-page":"16988","DOI":"10.18632\/oncotarget.24769","article-title":"Non-secretion of AFP and neutrophil lymphocyte ratio as predictors for survival in hepatocellular carcinoma patients treated with sorafenib: a large UK cohort","volume":"9","author":"Afshar","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.acra.2025.05.056_bib10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.acra.2025.05.056_bib11","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1007\/s00268-020-05698-6","article-title":"Pre-operative imaging characteristics in histology-proven resected intrahepatic cholangiocarcinoma","volume":"44","author":"Cheng","year":"2020","journal-title":"World J Surg"},{"key":"10.1016\/j.acra.2025.05.056_bib12","doi-asserted-by":"crossref","unstructured":"Liver EA for the S of the, Cancer EO for R and T of. EASL\u2013EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. Available from:J Hepatol [Internet] 2012 Apr 1;56(4):908\u2013943. doi:\u00a010.1016\/j.jhep.2011.12.001.","DOI":"10.1016\/j.jhep.2012.03.006"},{"issue":"1","key":"10.1016\/j.acra.2025.05.056_bib13","article-title":"Dynamic enhancement patterns of intrahepatic cholangiocarcinoma in cirrhosis on contrast-enhanced computed tomography: risk of misdiagnosis as hepatocellular carcinoma","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.acra.2025.05.056_bib14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41467-019-14050-z","article-title":"Intratumoral heterogeneity and clonal evolution in liver cancer","volume":"11","author":"Losic","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.acra.2025.05.056_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers15020365","article-title":"Radiomic analysis based on magnetic resonance imaging for predicting PD-L2 expression in hepatocellular carcinoma","volume":"15","author":"Tao","year":"2023","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.acra.2025.05.056_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","article-title":"Radiomics: extracting more information from medical images using advanced feature analysis","volume":"48","author":"Lambin","year":"2012","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.acra.2025.05.056_bib17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2015","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.acra.2025.05.056_bib18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2017.19163","article-title":"Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement","volume":"319","author":"McInnes","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.acra.2025.05.056_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"8","key":"10.1016\/j.acra.2025.05.056_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.acra.2025.05.056_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13244-023-01572-w","article-title":"METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII","volume":"15","author":"Kocak","year":"2024","journal-title":"Insights Imaging"},{"issue":"22","key":"10.1016\/j.acra.2025.05.056_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers15225373","article-title":"Differentiation of hepatocellular carcinoma from intrahepatic cholangiocarcinoma through MRI radiomics","volume":"15","author":"Liu","year":"2023","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.acra.2025.05.056_bib23","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1016\/j.clon.2023.01.018","article-title":"Computed tomography radiomics to differentiate intrahepatic cholangiocarcinoma and hepatocellular carcinoma","volume":"35","author":"Mahmoudi","year":"2023","journal-title":"Clin Oncol"},{"key":"10.1016\/j.acra.2025.05.056_bib24","article-title":"Classification of hepatocellular carcinoma and intrahepatic cholangiocarcinoma based on radiomic analysis","volume":"2022","author":"Xu","year":"2022","journal-title":"Comput Math Methods Med"},{"issue":"1","key":"10.1016\/j.acra.2025.05.056_bib25","first-page":"1","article-title":"Automated machine learning for differentiation of hepatocellular carcinoma from intrahepatic cholangiocarcinoma on multiphasic MRI","volume":"12","author":"Hu","year":"2022","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.acra.2025.05.056_bib26","doi-asserted-by":"crossref","first-page":"10161","DOI":"10.1007\/s00432-023-04935-4","article-title":"Differential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma based on spatial and channel attention mechanisms","volume":"149","author":"Huang","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.acra.2025.05.056_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.749137","article-title":"Clinical value of machine learning-based ultrasomics in preoperative differentiation between hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a multicenter study","volume":"11","author":"Ren","year":"2021","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.acra.2025.05.056_bib28","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s00261-023-03870-9","article-title":"Machine learning based on gadoxetic acid-enhanced MRI for differentiating atypical intrahepatic mass-forming cholangiocarcinoma from poorly differentiated hepatocellular carcinoma","volume":"48","author":"Chen","year":"2023","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.acra.2025.05.056_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7099476","article-title":"The application value of MRI T2(\u2217)WI radiomics nomogram in discriminating hepatocellular carcinoma from intrahepatic cholangiocarcinoma","volume":"2022","author":"Huang","year":"2022","journal-title":"Comput Math Methods Med"},{"issue":"8","key":"10.1016\/j.acra.2025.05.056_bib30","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.21037\/qims-21-1167","article-title":"18)F-FDG PET\/CT radiomic analysis for classifying and predicting microvascular invasion in hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"12","author":"Jiang","year":"2022","journal-title":"Quant Imaging Med Surg"},{"key":"10.1016\/j.acra.2025.05.056_bib31","article-title":"Differentiating HCC from ICC and prediction of ICC grade based on MRI deep-radiomics: using lesions and their extended regions","volume":"120","author":"Wang","year":"2024","journal-title":"Phys\u00a0Med"},{"issue":"7","key":"10.1016\/j.acra.2025.05.056_bib32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4329\/wjr.v16.i7.247","article-title":"Ultrasomics in liver cancer: developing a radiomics model for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma using contrast-enhanced ultrasound","volume":"16","author":"Su","year":"2024","journal-title":"World J Radiol"},{"issue":"1","key":"10.1016\/j.acra.2025.05.056_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13244-025-01904-y","article-title":"MRI-based deep learning radiomics to differentiate dual-phenotype hepatocellular carcinoma from HCC and intrahepatic cholangiocarcinoma: a multicenter study","volume":"16","author":"Wu","year":"2025","journal-title":"Insights Imaging"},{"issue":"7","key":"10.1016\/j.acra.2025.05.056_bib34","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/hepr.12605","article-title":"Sex-specific and race\/ethnicity-specific disparities in cholangiocarcinoma incidence and prevalence in the USA: An updated analysis of the 2000\u20132011 Surveillance, Epidemiology and End Results registry","volume":"46","author":"Mosadeghi","year":"2016","journal-title":"Hepatol Res"},{"issue":"12","key":"10.1016\/j.acra.2025.05.056_bib35","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41575-020-0314-8","article-title":"Modern therapeutic approaches for the treatment of malignant liver tumours","volume":"17","author":"Petrowsky","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"06","key":"10.1016\/j.acra.2025.05.056_bib36","first-page":"609","article-title":"Factors affecting the enhancement patterns of intrahepatic cholangiocarcinoma (ICC) on contrast-enhanced ultrasound (CEUS) and their pathological correlations in patients with a single lesion TT - Einflussfaktoren auf die Kontrast-Enhancement-Muster beim","volume":"37","author":"Yuan","year":"2016","journal-title":"Ultraschall Med"},{"issue":"3","key":"10.1016\/j.acra.2025.05.056_bib37","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1148\/radiol.12112308","article-title":"Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid\u2013enhanced MR images","volume":"264","author":"Kang","year":"2012","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.acra.2025.05.056_bib38","first-page":"54","article-title":"Progress and prospects of biomarkers in primary liver cancer (Review)","volume":"57","author":"Gao","year":"2020","journal-title":"Int J Oncol"},{"issue":"7","key":"10.1016\/j.acra.2025.05.056_bib39","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1007\/s00330-020-07562-6","article-title":"Preoperative classification of primary and metastatic liver cancer via machine learning-based ultrasound radiomics","volume":"31","author":"Mao","year":"2021","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.acra.2025.05.056_bib40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.suronc.2016.12.009","article-title":"Intrahepatic cholangiocarcinoma: molecular markers for diagnosis and prognosis","volume":"26","author":"Rahnemai-Azar","year":"2017","journal-title":"Surg Oncol"},{"key":"10.1016\/j.acra.2025.05.056_bib41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clinimag.2022.11.007","article-title":"CT radiomics for differentiating oncocytoma from renal cell carcinomas: systematic review and meta-analysis","volume":"94","author":"Dehghani Firouzabadi","year":"2023","journal-title":"Clin Imaging"},{"issue":"7","key":"10.1016\/j.acra.2025.05.056_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0287299","article-title":"CT radiomics for differentiating fat poor angiomyolipoma from clear cell renal cell carcinoma: systematic review and meta-analysis","volume":"18","author":"Dehghani Firouzabadi","year":"2023","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.acra.2025.05.056_bib43","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1016\/j.acra.2024.03.033","article-title":"Diagnostic performance of radiomics and deep learning to identify benign and malignant soft tissue tumors: a systematic review and meta-analysis","volume":"31","author":"Dai","year":"2024","journal-title":"Acad Radiol"},{"key":"10.1016\/j.acra.2025.05.056_bib44","article-title":"Diagnostic accuracy of deep learning and radiomics in lung cancer staging: a systematic review and meta-analysis","volume":"10","author":"Zheng","year":"2022","journal-title":"Front Public\u00a0Health"},{"key":"10.1016\/j.acra.2025.05.056_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.111129","article-title":"Radiomics diagnostic performance in predicting lymph node metastasis of papillary thyroid carcinoma: a\u00a0systematic review and meta-analysis","volume":"168","author":"HajiEsmailPoor","year":"2023","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.acra.2025.05.056_bib46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12880-025-01566-8","article-title":"A Bayesian meta-analysis on MRI-based radiomics for predicting EGFR mutation in brain metastasis of lung cancer","volume":"25","author":"Tabnak","year":"2025","journal-title":"BMC Med Imaging"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633225005331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633225005331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T21:03:13Z","timestamp":1763326993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633225005331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1076633225005331"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2025.05.056","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Performance of Radiomics for Differentiating Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2025.05.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Association of Academic Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}